A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretroviral therapy

Chinese Medical Journal

Volumn 118, Issue 7, 2005, Pages 609-611

  Zhou, Hua Ying ^a   Zheng, Yu Huang ^a   Zhang, Chun Ying ^a   Ding, Pei Pei ^a   Zou, Wen ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; DIDANOSINE; INDINAVIR; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA;

ADULT; ANEMIA; ARTICLE; BLOOD SAMPLING; CHINA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HELPER CELL; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; LIVER TOXICITY; LYMPHOCYTE COUNT; MALE; NAUSEA; OUTCOMES RESEARCH; PANCREATITIS; PERIPHERAL NEUROPATHY; PHENOTYPE; POLYMERASE CHAIN REACTION; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SUPPRESSOR CELL; VIRUS LOAD; VIRUS REPLICATION; VOMITING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; DIDANOSINE; FEMALE; HIV-1; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; NEVIRAPINE; RNA, VIRAL; STAVUDINE; T-LYMPHOCYTES;

EID: 17144372587     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Cao Y, Zhang FJ, Mei S, et al. The first clinical trial using triple therapy Combivir plus indinavir in Chinese individuals with HIV infection. Chin J Intern Med (Chin) 2002;41:109-113.
2. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-733.
3. Li L, Wei FL, Cao YZ, et al. Virological and immunological outcomes in HIV-1-infected Chinese patients treated with a combination of efavirenz and indinavir for 48 weeks. Chin J STD (Chin) 2002;8: 326-330.
4. Smiatacz T. Immune mechanisms in HIV infection and their role in antiretroviral therapy. Przegl Epidemiol 2003;57:309-316.
5. DHHS and Henry JK Family Foundation. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents 2002;19-21.
6. + lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 1999;103:1391-1398.
7. Hirsch HH, Kaufmann G, Sendi P, et al. Immune reconstitution in HIV infected patients. Clin Infect Dis 2004;38:1159-1166.
8. Kronenberg A, Riehle HM, Gunthard HF. Liver failure after long-term nucleoside antiretroviral therapy. Lancet 2001;358:759-760.